Please d Co hn eomt Ca do j mu s mt margins
Page 4 of 5
COMMUNICATION
ChemComm
N
N
A
pathway (b)
2009; (f) V. Gouverneur, and K. Müller, Fluorine in
DOI: 10.1039/C7CC08067K
pathway (a)
B
N
n
Pharmaceutical and Medicinal Chemistry, From Biophysical
N
[M L
x
]
M = Ru or Ir
Aspects to Clinical Applications, World Scientific Publishing
Company, 2012.
Hydro-
oxytetrafluoroethylation
n+1L
OAr
[MnL
L
= Phen or
ppy
[
M
x
]
x
]
Br(CF
2
)
2
pathway (a)
3
The properties of oxyfluoroalkyl compounds, see: (a) C.
Hansch, A. Leo, S. H. Unger, K. H. Kim, D. Nikaitani and E. J.
Lien, J. Med. Chem., 1973, 16, 1207; (b) C. Hansch, A. Leo, R.
W. Taft, Chem. Rev., 1991, 91, 165; (c) F. Leroux, P. Jeschke
and M. Schlosser, Chem. Rev., 2005, 105, 827; (d) P. Jeschke,
E. Baston, and F. R. Leroux, Mini-Rev. Med. Chem., 2007, 7,
n+1L
H-abstraction
[
M
x
]
-
H
Br
N
N
N
N
R
3
R
3
(CF
2
)
2
OAr
R
3
2 2
(CF )
OAr
(CF
2
)
2
OAr
R
1
R
2
R
1
R
2
R
1
R
2
A
1
or 4
5
pathway (b)
R
3
(CF
2
)
2
OAr
OAr
1027.
pathway (c)
radical propagation
Br-abstraction)
Br(CF
OAr
deprotonation
Photocatalytic
oxidation
R
1
R
2
4
5
6
Examples of aryloxyfluoroalkyl structural motifs in drugs and
biological active compounds, see: (a) J. Zhu, C. Ni, B. Gao and
J. Hu, J. Fluorine Chem., 2015, 171, 139; (b) T. Khotavivattana,
S. Calderwood, S. Verhoog, L. Pfeifer, S. Preshlock, N. Vasdev,
T. L. Collier and V. Gouverneur, Org. Lett., 2017, 19, 568.
Examples of fluoroalkylation reactions of alcohols, see: (a) J.
B. Liu, C. Chen, L. Chu, Z. H. Chen, X. H. Xu and F. L. Qing,
Angew. Chem. Int. Ed., 2015, 54, 11839; (b) J. B. Liu, X. H. Xu
and F. L. Qing, Org. Lett., 2015, 17, 5048; (c) J. W. Lee, D. N.
Spiegowski and M. -Y. Ngai, Chem. Sci., 2017, 8, 6066.
Examples on direct oxyfluoroalkylations, see: (a) F. R. Leroux,
B. Manteau, J. -P. Vors and S. Pazenok, Beilstein J. Org.
Chem., 2008, 4, 13; (b) T. Besset, P. Jubault, X. Pannecoucke
and T. Poisson, Org. Chem. Front., 2016, 3, 1004; (c) A. Tlili, F.
Toulgoat and T. Billard, Angew. Chem. Int. Ed., 2016, 55,
11726; (d) K. N. Lee, J. W. Lee and M. -Y. Ngai, Synlett, 2016,
27, 313.
(
- H
B
2 2
)
R
3
(CF
2
)
2
R3
2
(CF )
2OAr
Br
- HBr
R
1
R
2
R1 R2
HBr-elimination 3 or 5'
Oxytetrafluoroethylation
Scheme 2. Proposed mechanism for aryloxytetrafluoroethylation of heteroaromatics
and alkenes.
the hydrogen abstraction from ammonium radical cations,
which are formed from the corresponding tertiary amines via a
one-electron transfer to [M
cycle]. On the other hand, tetrafluoroethylated product 3 or 5'
would be generated from A by pathway (b) or (c). A one-
electron transfer from A to [M
carbocation intermediate B, which is deprotonated by TMEDA
to complete the reaction, providing product 3 or 5' [pathway
b)]. Alternatively, 3 or 5' can be generated by Br-abstraction
and HBr elimination processes, which involve radical
propagation to produce the key radical intermediate
n+1
+
x
L ] [pathway (a) in the catalytic
n+1
+
x
L ] produces the oxidized
7
For some recent reviews on visible-light-induced photo-
catalysis, see: (a) J. M. Narayanam, C. R. Stephenson, Chem.
Soc. Rev., 2011, 40, 102; (b) C. K. Prier, D. A. Rankic and D. W.
MacMillan, Chem. Rev., 2013, 113, 5322; (c) D. M. Schultz, T.
P. Yoon, Science, 2014, 343, 1239176; (d) T. Koike and M.
Akita, Top. Catal., 2014, 57, 967; (e) N. A. Romero and D. A.
(
Nicewicz, Chem. Rev., 2016, 116, 10075; (f) D. Cambie,
Bottecchia, N. J. W. Straathof, V. Hessel and T. Noel, Chem.
Rev., 2016, 116, 10276.
́
C.
·
(CF
2 2
) OAr [pathway (c)].
In summary, we have developed a practical visible-light-
̈
induced (hetero)aryloxytetrafluoroethylations of hetero-
aromatics and alkenes under mild reaction conditions. Two
functional groups consisting of oxygen and fluoroalkyl moieties
could be simultaneously installed into unactivated hetero-
aromatics and alkenes, demonstrating the potential use of the
method for late-stage modifications in the development of
functional molecules. In addition, this method can be utilized
for the fine-tuning of properties in drug development by
modifying the oxyfluoroalkyl reagent.
This research was supported by the Chung-Ang University
Graduate Research Scholarship in 2017 for Jisu Moon. We
gratefully acknowledge the National Research Foundation of
Korea [NRF-2012M3A7B4049657, NRF-2014-011165, NRF-
8
Accounts on our previous visible-light-induced fluoroalkyl-
ation reactions, see: (a) E. J. Cho, Chem. Rec., 2016, 16, 47; (b)
T. Chatterjee, N. Iqbal, Y. You and E. J. Cho, Acc. Chem. Res.,
2
016, 49, 2284.
Y. Choi, C. You, J. S. Kim and E. J. Cho, Org. Lett., 2016, 18,
246.
0 Synthesis of Br(CF
9
1
3
2 2
) OAr derivatives, see: J. Li, J. X. Qiao, D.
Smith, B. -C. Chen, M. E. Salvati, J. Y. Roberge and B. N.
Balasubramanian, Tetrahedron Lett., 2007, 48, 7516.
1
1 Previous examples on the formation of regioisomers in
visible-light-induced fluoroalkylations of indole, see: (a) D. A.
Nagib, D. W. MacMillan, Nature, 2011, 480, 224; (b) N. Iqbal,
S. Choi, E. Ko and E. J. Cho, Tetrahedron Lett., 2012, 53, 2005;
(c) J. Jung, E. Kim, Y. You and E. J. Cho, (d) N. J. W. Straathof,
H. P. L. Gemeots, X. Wang, J. C. Schouten, V. Hessel and T.
Noёl, Chemsuschem, 2014, 7, 1612.
2
016K1A3A1A19945930, and NRF-2017R1A2B2004082].
1
2 Used as an oxidizing additive for recovering aromaticity of
heteroaromatics, see: I. Abdiaj, C. Bottecchia, J. Alcazar and T.
Noёl, Synthesis, 2017, DOI: 10.1055/s-0036-1588527.
3 X. -J. Wei, W. Boon, V. Hessel and T. Noёl, ACS Catal., 2017, 7,
Notes and references
1
1
7136.
1
The properties of fluoroalkylated compounds, see: (a) M.
4 The results of Stern–Volmer experiments, conducted in our
previous fluoroalkylation works, showed that the
corresponding fluoroalkyl radicals were generated by
oxidative quenching pathways, see: ref. 11(c) and W. J. Choi,
S. Choi, K. Ohkubo, S. Fukuzumi, E. J. Cho and Y. You, Chem.
Sci., 2015, 6, 1454.
Shimizu and T. Hiyama, Angew. Chem. Int. Ed., 2004, 44, 214;
(
b) D. O'Hagan, Chem. Soc. Rev., 2008, 37, 308.
2
The applications of fluoroalkylated compounds in medical
fields, see: (a) K. Mu
̈
ller, C. Faeh and F. Diederich, Science,
007, 317, 1881; (b) W. K. Hagmann, J. Med. Chem. 2008, 51,
359; (c) J. Wang, M. Sanchez-Rosello, J. L. Acena, C. del
2
4
Pozo, A. E. Sorochinsky, S. Fustero, V. A. Soloshonok and H.
Liu, Chem. Rev., 2014, 114, 2432; (d) K. P. S. Cheung and G. C.
Tsui, Org. Lett., 2017, 19, 658; (e) I. Ojima, Fluorine in
4
| Chem. Commun., 2017, 00, 1-3
This journal is © The Royal Society of Chemistry 2017
Please do not adjust margins